Skip to main content
Top
Published in: International Journal of Clinical Oncology 2/2016

01-04-2016 | Original Article

Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial

Authors: Tomoya Yokota, Hiroyasu Igaki, Ken Kato, Yasuhiro Tsubosa, Junki Mizusawa, Hiroshi Katayama, Kenichi Nakamura, Haruhiko Fukuda, Yuko Kitagawa

Published in: International Journal of Clinical Oncology | Issue 2/2016

Login to get access

Abstract

Background

Accurate clinical evaluation of lymph nodes is crucial for selection of the optimum treatment strategy for individual esophageal cancer patients. This study investigated the accuracy of preoperative clinical diagnosis of lymph node metastasis for patients with clinical stage II/III esophageal squamous cell carcinoma.

Methods

Patients assigned to receive surgery and postoperative chemotherapy in JCOG9907 trial were studied to evaluate the concordance between clinical and pathological nodes. Preoperative diagnosis was based on computed tomography or magnetic resonance imaging.

Results

Among 166 patients in the postoperative group, 160 with sufficient pathological data were studied. The patient background characteristics were: male/female, 147/13; median age, 61 years (range 39–75 years); primary tumor site (upper/middle/lower), 15/76/69; cN0/cN1, 53/107. The sensitivity and specificity of clinical nodes for diagnosis of pathological nodes were 72.7 and 51.3 %, respectively; the positive and negative predictive values were 82.2 and 37.7 %, respectively. The lymph nodes overestimated in the preoperative diagnosis included thoracic paratracheal lymph nodes (#106) (n = 8), middle thoracic paraesophageal lymph nodes (#108) (n = 4), lymph nodes along the lesser curvature (#3) (n = 4), right cardiac lymph nodes (#1) (n = 3), and left cardiac lymph nodes (#2) (n = 2).

Conclusion

Diagnosis of clinical nodes has low specificity and low negative predictive value for prediction of pathological node category in the preoperative diagnosis of lymph node metastasis for patients with locally advanced resectable esophageal cancer. Clinical staging techniques must therefore be improved for accurate preoperative diagnosis.
Literature
1.
go back to reference Zhu Z, Chen H, Yu W et al (2014) Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy. Ann Surg Oncol 21:2857–2863CrossRefPubMed Zhu Z, Chen H, Yu W et al (2014) Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy. Ann Surg Oncol 21:2857–2863CrossRefPubMed
2.
go back to reference Abe S, Tachibana M, Shimokawa T et al (1989) Surgical treatment of advanced carcinoma of the esophagus. Surg Gynecol Obstet 168:115–120PubMed Abe S, Tachibana M, Shimokawa T et al (1989) Surgical treatment of advanced carcinoma of the esophagus. Surg Gynecol Obstet 168:115–120PubMed
3.
go back to reference Daly JM, Karnell LH, Menck HR (1996) National cancer data base report on esophageal carcinoma. Cancer 78:1820–1828CrossRefPubMed Daly JM, Karnell LH, Menck HR (1996) National cancer data base report on esophageal carcinoma. Cancer 78:1820–1828CrossRefPubMed
4.
go back to reference Iizuka T, Isono K, Kakegawa T et al (1989) Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Chest 96:1005–1011CrossRefPubMed Iizuka T, Isono K, Kakegawa T et al (1989) Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Chest 96:1005–1011CrossRefPubMed
5.
go back to reference Nishimaki T, Tanaka O, Suzuki T et al (1994) Patterns of lymphatic spread in thoracic esophageal cancer. Cancer 74:4–11CrossRefPubMed Nishimaki T, Tanaka O, Suzuki T et al (1994) Patterns of lymphatic spread in thoracic esophageal cancer. Cancer 74:4–11CrossRefPubMed
6.
go back to reference Fujita H, Kakegawa T, Yamana H et al (1995) Mortality and morbidity rates, postoperative course, quality of life and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 222:654–662CrossRefPubMedPubMedCentral Fujita H, Kakegawa T, Yamana H et al (1995) Mortality and morbidity rates, postoperative course, quality of life and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 222:654–662CrossRefPubMedPubMedCentral
7.
go back to reference Kato H, Watanabe H, Tachimori Y et al (1991) Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 51:931–935CrossRefPubMed Kato H, Watanabe H, Tachimori Y et al (1991) Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 51:931–935CrossRefPubMed
8.
go back to reference Kaklamanos IG, Walker GR, Ferry K et al (2003) Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10:754–761CrossRefPubMed Kaklamanos IG, Walker GR, Ferry K et al (2003) Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10:754–761CrossRefPubMed
9.
go back to reference Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12:681–692CrossRefPubMed Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12:681–692CrossRefPubMed
10.
go back to reference Ando N, Kato H, Igaki H et al (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74CrossRefPubMed Ando N, Kato H, Igaki H et al (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74CrossRefPubMed
11.
go back to reference Sobin LH, Wittekind C (2002) TNM classification of malignant tumors (UICC), 6th edn. Wiley-Liss, New York Sobin LH, Wittekind C (2002) TNM classification of malignant tumors (UICC), 6th edn. Wiley-Liss, New York
12.
go back to reference Japanese Society for Esophageal Diseases (2004) Guideline for clinical and pathological studies on carcinoma of the esophagus, 9th edn. Esophagus 1:61–88 Japanese Society for Esophageal Diseases (2004) Guideline for clinical and pathological studies on carcinoma of the esophagus, 9th edn. Esophagus 1:61–88
13.
go back to reference Yokota T, Ando N, Igaki H et al. (2015) Prognostic factors in patients receiving neoadjuvant 5-fluorouracil plus cisplatin for advanced esophageal cancer (JCOG9907). Oncology 89:143–151CrossRefPubMed Yokota T, Ando N, Igaki H et al. (2015) Prognostic factors in patients receiving neoadjuvant 5-fluorouracil plus cisplatin for advanced esophageal cancer (JCOG9907). Oncology 89:143–151CrossRefPubMed
14.
go back to reference Hoelscher AH, Dittler HJ, Siewert JR (1994) Staging of squamous esophageal cancer: accuracy and value. World J Surg 18:312–320CrossRef Hoelscher AH, Dittler HJ, Siewert JR (1994) Staging of squamous esophageal cancer: accuracy and value. World J Surg 18:312–320CrossRef
15.
go back to reference Tio TL, Coene PPLO, Schouwink MH et al (1989) Esophagogastric carcinoma: preoperative TNM classification with endosonography. Radiology 173:411–417CrossRefPubMed Tio TL, Coene PPLO, Schouwink MH et al (1989) Esophagogastric carcinoma: preoperative TNM classification with endosonography. Radiology 173:411–417CrossRefPubMed
16.
go back to reference Botet JF, Lightdale CJ, Zauber AG et al (1991) Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 181:419–425CrossRefPubMed Botet JF, Lightdale CJ, Zauber AG et al (1991) Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 181:419–425CrossRefPubMed
17.
go back to reference Nishimaki T, Tanaka O, Ando N et al (1999) Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg 68(6):2059–2064CrossRefPubMed Nishimaki T, Tanaka O, Ando N et al (1999) Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg 68(6):2059–2064CrossRefPubMed
18.
go back to reference Kuge K, Murakami G, Mizobuchi S et al (2003) Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg 125:1343–1349CrossRefPubMed Kuge K, Murakami G, Mizobuchi S et al (2003) Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg 125:1343–1349CrossRefPubMed
19.
go back to reference Ding X, Zhang J, Li B et al (2002) A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol 85:1019 Ding X, Zhang J, Li B et al (2002) A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol 85:1019
20.
go back to reference Kienle P, Buhl K, Kuntz C et al (2002) Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia. Digestion 66:230–236CrossRefPubMed Kienle P, Buhl K, Kuntz C et al (2002) Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia. Digestion 66:230–236CrossRefPubMed
21.
go back to reference Halvorsen RA, Thompson WM (1984) Computed tomographic evaluation of esophageal carcinoma. Semin Oncol 11:113–126PubMed Halvorsen RA, Thompson WM (1984) Computed tomographic evaluation of esophageal carcinoma. Semin Oncol 11:113–126PubMed
22.
go back to reference Lerut T, Flamen P, Ectors N et al (2000) Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232:743–752CrossRefPubMedPubMedCentral Lerut T, Flamen P, Ectors N et al (2000) Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232:743–752CrossRefPubMedPubMedCentral
23.
Metadata
Title
Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial
Authors
Tomoya Yokota
Hiroyasu Igaki
Ken Kato
Yasuhiro Tsubosa
Junki Mizusawa
Hiroshi Katayama
Kenichi Nakamura
Haruhiko Fukuda
Yuko Kitagawa
Publication date
01-04-2016
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2016
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-015-0899-z

Other articles of this Issue 2/2016

International Journal of Clinical Oncology 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine